Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  September 12, 2025
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  November 13, 2025
Memoranda
EPA Proposes to Narrow Scope of TSCA Section 8(a)(7) PFAS Reporting Rule; Exemptions Would Include De Minimis Amounts, Imported Articles

On November 13, 2025, the U.S. Environmental Protection Agency (EPA) issued a proposed rule to amend the Toxic Substances Control Act (TSCA) Section...

  October 24, 2025
Memoranda
AICIS Will Require Information on 522 PFAS Imported or Manufactured in Australia

On October 14, 2025, the Australia Industrial Chemicals Introduction Scheme (AICIS) announced that it has initiated an evaluation on the introduction...

  October 15, 2025
Memoranda
New Mexico Publishes Proposed Rule to Implement PFAS Protection Act, Will Hold Webinar on October 22, 2025

Following up on the New Mexico Environment Department’s (NMED) September 25, 2025, webinar on a labeling requirement for products containing...

  October 14, 2025
Global Regulatory Updates
Global Regulatory Developments for October 2025

Register Now For “Phthalate Risk Evaluation under TSCA and the Potential Impacts to the Plastics Industry,” October 30, 2025, 11:00...

  September 24, 2025
Memoranda
EPA Proposes to Amend TSCA Risk Evaluation Framework

On September 23, 2025, the U.S. Environmental Protection Agency (EPA) proposed highly anticipated amendments to the procedural framework rule for...

Seminars & Webinars

  November 10, 2025
Seminars & Webinars
31st Annual Green Chemistry Challenge Awards: New Categories and Expanded Opportunities, December 4, 2025 11:00 a.m. – 12:00 p.m. (EST), via webinar

The Acta Group (Acta®) affiliate Bergeson & Campbell, P.C. (B&C®) and the American Chemical Society (ACS) are pleased to present "31st...

  November 3, 2025
Seminars & Webinars
HCPA 2025 Annual Meeting, December 7-10, 2025, Fort Lauderdale, FL

HCPA’s Annual Meeting engages on the public policy issues that impact the household and commercial products industry. Thought leaders will discuss...

  October 29, 2025
Seminars & Webinars
TSCA Developments 2026, February 5, 2026, via webinar

Chemical Watch presents TSCA Developments 2026, covering TSCA and its business-critical implications, including risk evaluation and management rules,...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, and five Ph.D.’s. Government affairs and regulatory specialists including four high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.